AzTrials
AzTrials

Traumatic Brain InjuryNCT03539848

Diagnosis of mTBI in a Community Setting

A study testing I-PAS Goggles in people with Traumatic Brain Injury and Mild Traumatic Brain Injury, run by University of Miami at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this research study is to test whether a portable goggle system (I-PAS) is good at diagnosing mild traumatic brain injury (mTBI) in a community setting. The goal is to determine whether the IPAS goggle system can be used reliably in an urgent care or emergency department setting. Read more about this study

Who is it for?
Ages 18 to 50 years
What is being tested?
I-PAS Goggles
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited States
Study dates
1 Aug 2018to 30 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

None listed.

Who cannot join

  • History of head injury characterized by any of the following:
  • Resulting from penetrating trauma
  • Resulting from an automobile accident with significant associated injuries
  • Associated with a Glasgow Comma Scale Score of less than 13 at the time of injury
  • Associated with a loss of consciousness period greater than 59 minutes
  • Judged to be more than mild by Medical Staff
Show all 26Show fewer
  • Requiring admission to the hospital for any reason
  • Associated with subdural or epidural hemorrhage
  • Head injury history
  • For control group - history of head injury within the last six months or currently experience any head injury symptoms at time of enrollment
  • For head injured group - history of head injury within the last three months or experiencing head injury symptoms immediately prior to the current head injury
  • Presence of severe aphasia
  • History of diagnosed neuropsychiatric disorders (e.g. hypochondriasis, major depression, schizophrenia)
  • Documented neurodegenerative disorders
  • Pregnancy [Female candidates will be asked if they are pregnant]
  • Prior disorders of hearing and balance including:
  • Meniere's disease
  • Multiple sclerosis
  • Vestibular neuritis
  • Vestibular schwannoma
  • Sudden sensorineural hearing loss
  • History of Cerebrovascular disorders
  • History of ear operation other than myringotomy and tube placement in the past
  • Systemic disorders to include chronic renal failure, cirrhosis of the liver, autoimmune disease, heart disease, lung disease, or severe arthritis
  • Children
  • Individuals who cannot provide informed consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Miami Miller School of Medicine

    Miami, Florida, 33136

Other trials in United States

About this study

Official title: The Use of a Portable 3D Head Mounted Display (HMD) With Integrated Eye Capture Technology (IPAS Goggles) for the Diagnosis of Mild Traumatic Brain Injury (mTBI) in a Community Setting

The purpose of this research study is to test whether a portable goggle system (I-PAS) is good at diagnosing mild traumatic brain injury (mTBI) in a community setting. The goal is to determine whether the IPAS goggle system can be used reliably in an urgent care or emergency department setting.

Read the detailed description

The purpose of this research study is to test whether a portable goggle system (I-PAS) is good at diagnosing mild traumatic brain injury (mTBI) in a community setting. The goal is to determine whether the IPAS goggle system can be used reliably in an urgent care or emergency department setting. The study further looks at current metrics and compares their efficacy in both the diagnosis and prognostic value of individuals with mTBI.

Being tested
I-PAS Goggles
Keywords
TBI, Community Setting, Mild TBI
Medical subject headings
Brain Injuries, Traumatic, Brain Concussion, Brain Injuries, Craniocerebral Trauma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • I-PAS GogglesDevice

    Portable, head-mounted display goggle system with integrated eye capture technology

Study groups in NCT03539848
Study groupRoleWhat they receive
Subjects with mTBIExperimentalIndividuals who come to the emergency department or urgent/acute care facility with an mTBI will undergo testing with the I-PAS Goggles.
Receives: Device: I-PAS Goggles
Subjects with minor injuriesActive comparatorIndividuals who come to the emergency department or urgent/acute care facility with minor injuries (such as ankle sprains or knee sprains) will undergo testing with the I-PAS Goggles.
Receives: Device: I-PAS Goggles

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with mTBI

    How many participants were detected to have mTBI following an injury.

    Measured: 33 months

Secondary outcomes (1)
  1. Time to recover

    Measuring the time (days) it takes for readiness to return to normal activity after a head injury for participants with a detected mTBI

    Measured: 33 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2018
  2. Study start1 Aug 2018
  3. Primary completion30 Apr 2025
  4. Study completion30 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03539848
Sponsor's protocol ID
20180012
Status last verified
Aug 2024
First submitted
15 May 2018
Last updated
2 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing I-PAS Goggles in people with Traumatic Brain Injury and Mild Traumatic Brain Injury, run by University of Miami at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 26 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with mTBI (time frame: 33 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in